Emodin Reverses Gemcitabine Resistance in Pancreatic Cancer Cells via the Mitochondrial Apoptosis Pathway in Vitro

International Journal of Oncology - Greece
doi 10.3892/ijo.2011.1285
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Hypoxia Increases Resistance of Human Pancreatic Cancer Cells to Apoptosis Induced by Gemcitabine

Clinical Cancer Research
Cancer ResearchOncology
2004English

Furosemide Reverses Multidrug Resistance Status in Bladder Cancer Cells in Vitro

Journal of Clinical Pathology
MedicineForensic MedicinePathology
2006English

Three-Dimensional Collagen I Promotes Gemcitabine Resistance in Vitro in Pancreatic Cancer Cells Through HMGA2-Dependent Histone Acetyltransferase Expression

PLoS ONE
Multidisciplinary
2013English

Loss of PDPK1 Abrogates Resistance to Gemcitabine in Label-Retaining Pancreatic Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Emodin Sensitizes Paclitaxel-Resistant Human Ovarian Cancer Cells to Paclitaxel-Induced Apoptosis in Vitro

Oncology Reports
MedicineCancer ResearchOncology
2009English

Anthraquinone G503 Induces Apoptosis in Gastric Cancer Cells Through the Mitochondrial Pathway

PLoS ONE
Multidisciplinary
2014English

Activin a Induces Apoptosis of Mouse Myeloma Cells via the Mitochondrial Pathway

Oncology Letters
Cancer ResearchOncology
2017English

Emodin Sensitizes Human Pancreatic Cancer Cells to EGFR Inhibitor Through Suppressing Stat3 Signaling Pathway

Cancer Management and Research
Oncology
2019English

Eryngium Billardieri Induces Apoptosis via Bax Gene Expression in Pancreatic Cancer Cells

Advanced Pharmaceutical Bulletin
ToxicologyPharmaceuticsPharmacologyPharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy